Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Symphonix gets European approval for hearing device:

This article was originally published in Clinica

Executive Summary

US firm Symphonix Devices has CE-marked a new semi-implantable hearing device which can be used on people unsuitable for conventional hearing aids. The Vibrant soundbridge and a second-generation programmable version are designed to treat sensorineural hearing loss. They use a floating mass transducer, the size of a grain of rice, which when implanted in the middle ear converts sound from the externally worn receiver into mechanical energy in the form of vibrations. These vibrations stimulate the inner ear and the auditory nerve. Sales of the devices will begin in the second quarter of 1998.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel